Free Trial
LON:C4XD

C4X Discovery (C4XD) Share Price, News & Analysis

C4X Discovery logo
GBX 12 +2.58 (+27.32%)
(As of 04/25/2024)

About C4X Discovery Stock (LON:C4XD)

Key Stats

Today's Range
8.30
12
50-Day Range
12
12
52-Week Range
7
22
Volume
3.77 million shs
Average Volume
1.18 million shs
Market Capitalization
£30.27 million
P/E Ratio
300.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.

Receive C4XD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter.

C4XD Stock News Headlines

JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
See More Headlines

C4XD Stock Analysis - Frequently Asked Questions

C4X Discovery's stock was trading at GBX 9 on January 1st, 2024. Since then, C4XD stock has increased by 33.3% and is now trading at GBX 12.
View the best growth stocks for 2024 here
.

C4X Discovery Holdings plc (LON:C4XD) posted its earnings results on Wednesday, April, 29th. The company reported ($5.02) EPS for the quarter, beating the consensus estimate of ($5.50) by $0.48. C4X Discovery had a trailing twelve-month return on equity of 55.38% and a net margin of 42.81%.

Shares of C4XD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that C4X Discovery investors own include The Berkeley Group (BKG), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC) and Intel (INTC).

Company Calendar

Last Earnings
4/29/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
£10.57 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£24.68 million
Cash Flow
GBX 3 per share
Book Value
GBX 10 per share

Miscellaneous

Free Float
N/A
Market Cap
£30.27 million
Optionable
Not Optionable
Beta
0.23
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (LON:C4XD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners